🇺🇸
SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ — Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Lilly Gateway Labs is a…
Source: prnewswire
Country: United States